These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 24623536

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
    Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W.
    J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
    [Abstract] [Full Text] [Related]

  • 23. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K.
    FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
    [Abstract] [Full Text] [Related]

  • 24. Current understanding and management of giant cell arteritis and polymyalgia rheumatica.
    Ghosh P, Borg FA, Dasgupta B.
    Expert Rev Clin Immunol; 2010 Nov; 6(6):913-28. PubMed ID: 20979556
    [Abstract] [Full Text] [Related]

  • 25. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L, Spiera R.
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [Abstract] [Full Text] [Related]

  • 26. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
    Rovenský J, Tuchynová A, Poprac P, Blazíková S, Bosák V, Stvrtinová V.
    Vnitr Lek; 2006 Dec; 52(7-8):691-6. PubMed ID: 16967610
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
    Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M.
    Cytokine; 2008 Nov; 44(2):207-20. PubMed ID: 18986814
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 31. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR, Athanasiov PA, Crompton JL.
    Aust Fam Physician; 2006 Nov 01; 35(11):889-91. PubMed ID: 17099810
    [Abstract] [Full Text] [Related]

  • 32. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE, Harris E, Mathieson H, Sorensen L, Luqmani R, McGettrick HM, Morgan AW, Young SP, Mackie SL.
    J Autoimmun; 2024 Jul 01; 147():103260. PubMed ID: 38797046
    [Abstract] [Full Text] [Related]

  • 33. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S, Ramos-Remus C, Davis P.
    J Rheumatol; 1998 Jan 01; 25(1):99-104. PubMed ID: 9458211
    [Abstract] [Full Text] [Related]

  • 34. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
    Chatelain D, Duhaut P, Loire R, Bosshard S, Pellet H, Piette JC, Sevestre H, Ducroix JP.
    Arthritis Rheum; 2008 Aug 01; 58(8):2565-73. PubMed ID: 18668584
    [Abstract] [Full Text] [Related]

  • 35. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis.
    Álvarez Rodríguez L, López-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marín MJ, Fernández-Luna JL, Aguero Balbín J, Aranzamendi Zaldunbide M, Blanco R, Martínez-Taboada VM.
    Ann Rheum Dis; 2011 Sep 01; 70(9):1677-83. PubMed ID: 21670089
    [Abstract] [Full Text] [Related]

  • 36. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.
    Hysa E, Casabella A, Gotelli E, Campitiello R, Schenone C, Genova C, Tanda ET, Sulli A, Smith V, Cimmino MA, Paolino S, Cutolo M.
    Autoimmun Rev; 2024 Sep 01; 23(7-8):103589. PubMed ID: 39117006
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 01; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
    Liozon E, Ouattara B, Rhaiem K, Ly K, Bezanahary H, Loustaud V, Letellier P, Drouet M, Vidal E.
    Clin Exp Rheumatol; 2009 Apr 01; 27(1 Suppl 52):S89-94. PubMed ID: 19646354
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.